-
Sarepta Therapeutics' (SRPT) Overweight Rating Reiterated at Cantor Fitzgerald
Источник: Buzz FX / 19 мар 2025 08:46:18 America/Chicago
Sarepta Therapeutics' (SRPT) Overweight Rating Reiterated at Cantor Fitzgerald Written by MarketBeat March 19, 2025 Share Link copied to clipboard. Remove Ads Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) 's stock had its "overweig
Read more...